tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

BIIB Stock Latest News

Biogen’s Hold Rating: Balancing Promising Growth with Revenue Challenges and Infrastructure Development
RatingsBiogen’s Hold Rating: Balancing Promising Growth with Revenue Challenges and Infrastructure Development
6h ago
BIIB
Biogen to highlight progress in rare kidney disease at ASN Kidney Week
PremiumThe Fly
Biogen to highlight progress in rare kidney disease at ASN Kidney Week
11h ago
BIIB
Biogen price target raised to $157 from $155 at Bernstein
PremiumThe Fly
Biogen price target raised to $157 from $155 at Bernstein
12h ago
BIIB
Biogen’s Earnings Call Highlights Robust Growth and Positive Outlook
PremiumCompany Announcements
Biogen’s Earnings Call Highlights Robust Growth and Positive Outlook
3d ago
BIIB
Biogen’s Strategic Advancements and Diversification Drive Buy Rating
PremiumRatings
Biogen’s Strategic Advancements and Diversification Drive Buy Rating
3d ago
BIIB
Biogen’s Market Challenges and Opportunities: Hold Rating Amid Competitive Pressures and Strategic Uncertainties
PremiumRatingsBiogen’s Market Challenges and Opportunities: Hold Rating Amid Competitive Pressures and Strategic Uncertainties
3d ago
BIIB
Biogen price target lowered to $250 from $255 at Baird
Premium
The Fly
Biogen price target lowered to $250 from $255 at Baird
3d ago
BIIB
Biogen’s Balanced Risk-Reward Scenario: Hold Rating Amidst Strong Legacy Performance and Strategic Challenges
Premium
Ratings
Biogen’s Balanced Risk-Reward Scenario: Hold Rating Amidst Strong Legacy Performance and Strategic Challenges
4d ago
BIIB
Biogen Inc. Reports Strong Q3 2025 Results
PremiumCompany Announcements
Biogen Inc. Reports Strong Q3 2025 Results
4d ago
BIIB
Biogen’s Resilient Performance and Growth Prospects Justify Buy Rating
PremiumRatings
Biogen’s Resilient Performance and Growth Prospects Justify Buy Rating
4d ago
BIIB
Morning Movers: Alphabet, Eli Lilly rise following quarterly results
PremiumThe Fly
Morning Movers: Alphabet, Eli Lilly rise following quarterly results
4d ago
CI
MA
Biogen’s Strong Financial Performance and Strategic Positioning Justify Buy Rating
PremiumRatings
Biogen’s Strong Financial Performance and Strategic Positioning Justify Buy Rating
4d ago
BIIB
Biogen reports Q3 EPS $4.81, consensus $3.88
PremiumThe FlyBiogen reports Q3 EPS $4.81, consensus $3.88
5d ago
BIIB
Biogen lowers FY25 EPS view to $14.50-$15.00 from $15.50-$16.00
Premium
The Fly
Biogen lowers FY25 EPS view to $14.50-$15.00 from $15.50-$16.00
5d ago
BIIB
Notable companies reporting before tomorrow’s open
Premium
The Fly
Notable companies reporting before tomorrow’s open
5d ago
K
CI
BIIB Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
BIIB Upcoming Earnings Report: What to Expect?
7d ago
BIIB
Biogen’s Strategic Positioning and Promising Pipeline Drive Buy Rating
PremiumRatings
Biogen’s Strategic Positioning and Promising Pipeline Drive Buy Rating
7d ago
BIIB
Biogen’s PMN Study: A Potential Game-Changer for Kidney Disease Treatment?
PremiumCompany Announcements
Biogen’s PMN Study: A Potential Game-Changer for Kidney Disease Treatment?
7d ago
BIIB
Biogen’s Felzartamab Trial: A New Hope for Kidney Transplant Patients
PremiumCompany Announcements
Biogen’s Felzartamab Trial: A New Hope for Kidney Transplant Patients
7d ago
BIIB
Biogen’s Litifilimab Study: A Potential Game-Changer for Lupus Treatment?
PremiumCompany AnnouncementsBiogen’s Litifilimab Study: A Potential Game-Changer for Lupus Treatment?
7d ago
BIIB
Biogen’s Litifilimab Study: A Promising Step for Lupus Treatment
Premium
Company Announcements
Biogen’s Litifilimab Study: A Promising Step for Lupus Treatment
7d ago
BIIB
Biogen’s New Study on Felzartamab: A Potential Game-Changer for Kidney Transplant Patients
Premium
Company Announcements
Biogen’s New Study on Felzartamab: A Potential Game-Changer for Kidney Transplant Patients
7d ago
BIIB

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >